These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 499100)

  • 1. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
    Waldhäusl W; Bratusch-Marrain P; Nowotny P
    Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
    Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
    J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
    Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
    Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic action of somatostatin after oral glucose loading: due to suppression of glucagon and growth hormone or of intestinal carbohydrate absorption?
    Bratusch-Marrain P; Vierhapper H; Grubeck-Loebenstein B; Waldhäusl W; Nowotny P
    Horm Metab Res; 1981 Jun; 13(6):305-9. PubMed ID: 6114914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics].
    Ferrero E; Casale G; Tassi G; Ciaponi A
    Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of pronounced hyperkalaemia after arginine infusion in the diabetic subject.
    Massara F; Cagliero E; Bisbocci D; Passarino G; Carta Q; Molinatti GM
    Diabete Metab; 1981 Sep; 7(3):149-53. PubMed ID: 7319114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects.
    Coppola L; Giugliano D; Tirelli A; Misso L; Sgambato S; D'Onofrio F
    Diabete Metab; 1980 Dec; 6(4):245-9. PubMed ID: 6110570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis.
    Saudek CD; Finkowski M; Knopp RH
    J Clin Invest; 1975 Jan; 55(1):180-7. PubMed ID: 1109177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans.
    Broglio F; Gottero C; Prodam F; Destefanis S; Gauna C; Me E; Riganti F; Vivenza D; Rapa A; Martina V; Arvat E; Bona G; van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):503-9. PubMed ID: 15473884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetogenic action of GH and cortisol in insulin-dependent diabetes mellitus. Aspects of the mechanisms behind the Somogyi phenomenon.
    Kollind M; Adamson U; Lins PE; Efendic S
    Horm Metab Res; 1987 Apr; 19(4):156-9. PubMed ID: 2884179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
    Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF
    J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of somatostatin in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C; Beck B; Kolopp M; Toussain P; Debry G
    Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.